Nuo Therapeutics, Inc. (AURX) Operating income 2015–2025
Nuo Therapeutics, Inc. (AURX) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2025 · since FY2015: -$41.3M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.5M | -2.4% |
| FY2024 | -$2.5M | +22.4% |
| FY2023 | -$3.2M | +4.6% |
| FY2022 | -$3.3M | -3562.3% |
| FY2021 | -$90,670 | +76.0% |
| FY2020 | -$378,059 | +61.0% |
| FY2019 | -$969,198 | +35.6% |
| FY2018 | -$1.5M | +90.3% |
| FY2017 | -$15.5M | — |
| FY2015 | -$41.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice